Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moran

Showing results (271-280 of 332) with videos related to

Pageof 34
Sort By:
BMC Nephrology|January 16, 2017
Acute and chronic kidney disease in elderly patients with hip fracture: prevalence, risk factors and outcome with development and validation of a risk prediction model for acute kidney injuryChristine J Porter, Iain K Moppett, Irene Juurlink, et al.
Annals of the Royal College of Surgeons of England|August 24, 2016
The effect of surgical experience on the amount of radiation exposure from fluoroscopy during dynamic hip screw fixationC Quah, R Mehta, F S Shivji, et al.
The Journal of Biological Chemistry|August 29, 2014
Mammalian mitochondrial and cytosolic folylpolyglutamate synthetase maintain the subcellular compartmentalization of folatesScott A Lawrence, Steven A Titus, Jennifer Ferguson, et al.
Eclinicalmedicine|June 14, 2019
Changing the System - Major Trauma Patients and Their Outcomes in the NHS (England) 2008-17Christopher G Moran, Fiona Lecky, Omar Bouamra, et al.
Molecular Pharmacology|February 1, 1994
A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogsP C Sanghani, A Jackman, V R Evans, et al.
The Journal of Bone and Joint Surgery. British Volume|February 29, 2012
Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitalsR N Thompson, J R A Phillips, S H J McCauley, et al.
Cancer Research|May 15, 1996
Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acidT Alati, J F Worzalla, C Shih, et al.
Biochemistry|February 19, 1991
Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferaseS W Baldwin, A Tse, L S Gossett, et al.
Environmental Technology|October 29, 2015
Use of agave bagasse for production of an organic fertilizer by pretreatment with Bjerkandera adusta and vermicomposting with Eisenia fetidaRene G Moran-Salazar, Erika N Marino-Marmolejo, Jacobo Rodriguez-Campos, et al.
Cancer Research|September 1, 1990
Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivoA L Jackman, G A Taylor, B M O'Connor, et al.
Pageof 34

Showing results (271-280 of 332) with videos related to

Sort By:
Pageof 34
BMC Nephrology|January 16, 2017
Acute and chronic kidney disease in elderly patients with hip fracture: prevalence, risk factors and outcome with development and validation of a risk prediction model for acute kidney injuryChristine J Porter, Iain K Moppett, Irene Juurlink, et al.
Annals of the Royal College of Surgeons of England|August 24, 2016
The effect of surgical experience on the amount of radiation exposure from fluoroscopy during dynamic hip screw fixationC Quah, R Mehta, F S Shivji, et al.
The Journal of Biological Chemistry|August 29, 2014
Mammalian mitochondrial and cytosolic folylpolyglutamate synthetase maintain the subcellular compartmentalization of folatesScott A Lawrence, Steven A Titus, Jennifer Ferguson, et al.
Eclinicalmedicine|June 14, 2019
Changing the System - Major Trauma Patients and Their Outcomes in the NHS (England) 2008-17Christopher G Moran, Fiona Lecky, Omar Bouamra, et al.
Molecular Pharmacology|February 1, 1994
A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogsP C Sanghani, A Jackman, V R Evans, et al.
The Journal of Bone and Joint Surgery. British Volume|February 29, 2012
Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitalsR N Thompson, J R A Phillips, S H J McCauley, et al.
Cancer Research|May 15, 1996
Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acidT Alati, J F Worzalla, C Shih, et al.
Biochemistry|February 19, 1991
Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferaseS W Baldwin, A Tse, L S Gossett, et al.
Environmental Technology|October 29, 2015
Use of agave bagasse for production of an organic fertilizer by pretreatment with Bjerkandera adusta and vermicomposting with Eisenia fetidaRene G Moran-Salazar, Erika N Marino-Marmolejo, Jacobo Rodriguez-Campos, et al.
Cancer Research|September 1, 1990
Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivoA L Jackman, G A Taylor, B M O'Connor, et al.
Pageof 34